EUCTR2008-004584-19-DK进行中（未招募）1 期
Skolioser hos cerebral parese patienter behandlet med Botulinum toxin AInjektioner.
niversity hospital of Hvidovre0 个研究点目标入组 33 人开始时间: 2008年8月13日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Cerebral palsy patients with neuromuscular scoliosis in the age from 2 to 18 years.
- •2. Need to treat the scoliosis and no prior surgery.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Allergy or toxic reaction to botulinum toksin type A.
- •2. In case of infection at the injection site.
- •3. Patients with prior treatment with BTXA within 6 months.
研究者
相似试验
尚未招募
不适用
Bone deformities in patients with cerebral palsyanatomical variation in bonestructuresDeformities of the bones1000595910028037NL-OMON35180Academisch Medisch Centrum10
已完成
不适用
Fusionless treatment of idiopathic scoliosis with the MIScoli™ system during the growth period (FUTURE)Current condition as of 27/10/2021: Major thoracic scoliosis with Cobb Angle greater than 40° and less than 70° and Lenke I, II or V curve pattern. Children/adolescents with curves greater than 30° with attempted but failed brace treatment are also potential candidates for this study._____Previous Condition:Major thoracic scoliosis with Cobb Angle greater than 40° and Lenke I, II and V curve pattern.Musculoskeletal DiseasesISRCTN10892409Spino Modulation Inc59
已完成
2 期
Ayurvedic Management of Paralysis in ChildreCTRI/2019/06/019645All India Institute of Ayurveda30
已完成
1 期
Cerebral palsy and its management with ayurvedaCTRI/2011/12/002298Institute for Post Graduate Teaching and Research in Ayurveda16
已完成
不适用
ANTIPARASITIC THERAPY FOR NEUROCYSTICERCOSIS: PHASE II / III STUDY ON SAFETY AND EFFECTIVENESS AND COMBINED TREATMENT OF PRAZICUANTEL AND ALBENDAZOLE-B690 Cysticercosis of central nervous systemCysticercosis of central nervous systemB690PER-121-06INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS,124